Search research articles
Contact Us
Filters
Showing results (51-60 of 149) with videos related to
Page
of 15
Sort By:
The American Journal of Psychiatry
|
February 1, 1990
Antisocial personality disorder in patients with substance abuse disorders: a problematic diagnosis?
L J Gerstley, A I Alterman, A T McLellan, et al.
The Journal of Nervous and Mental Disease
|
April 1, 1981
Are the "addiction-related" problems of substance abusers really related?
A T McLellan, L Luborsky, G E Woody, et al.
Substance Abuse and Rehabilitation
|
June 21, 2011
Differences in onset and abuse/dependence episodes between prescription opioids and heroin: results from the National Epidemiologic Survey on Alcohol and Related Conditions
Li-Tzy Wu, George E Woody, Chongming Yang, et al.
Drug and Alcohol Dependence
|
August 7, 2013
Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior--outcomes of a randomized trial
David Otiashvili, Gvantsa Piralishvili, Zura Sikharulidze, et al.
Journal of Psychiatric Research
|
July 12, 2011
Substance use disorders and comorbid Axis I and II psychiatric disorders among young psychiatric patients: findings from a large electronic health records database
Li-Tzy Wu, Ken Gersing, Bruce Burchett, et al.
The Clinical Journal of Pain
|
December 24, 2010
Economic costs of nonmedical use of prescription opioids
Ryan N Hansen, Gerry Oster, John Edelsberg, et al.
Journal of Substance Abuse Treatment
|
December 3, 2014
Opioid addicted buprenorphine injectors: drug use during and after 12-weeks of buprenorphine-naloxone or methadone in the Republic of Georgia
Gvantsa Piralishvili, David Otiashvili, Zura Sikharulidze, et al.
Drug and Alcohol Dependence
|
December 2, 2009
Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid-dependent youth: secondary analyses from a NIDA Clinical Trials Network study
Amit Chakrabarti, George E Woody, Margaret L Griffin, et al.
The Psychiatric Clinics of North America
|
September 1, 1986
Psychotherapy for substance abuse
G E Woody, A T McLellan, L Luborsky, et al.
Journal of Substance Abuse Treatment
|
January 1, 1990
Detoxification with phenobarbital of alprazolam-dependent polysubstance abusers
N V Ravi, I Maany, W M Burke, et al.
Page
of 15
Search research articles
Search
Showing results (51-60 of 149) with videos related to
Sort By:
Page
of 15
The American Journal of Psychiatry
|
February 1, 1990
Antisocial personality disorder in patients with substance abuse disorders: a problematic diagnosis?
L J Gerstley, A I Alterman, A T McLellan, et al.
The Journal of Nervous and Mental Disease
|
April 1, 1981
Are the "addiction-related" problems of substance abusers really related?
A T McLellan, L Luborsky, G E Woody, et al.
Substance Abuse and Rehabilitation
|
June 21, 2011
Differences in onset and abuse/dependence episodes between prescription opioids and heroin: results from the National Epidemiologic Survey on Alcohol and Related Conditions
Li-Tzy Wu, George E Woody, Chongming Yang, et al.
Drug and Alcohol Dependence
|
August 7, 2013
Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior--outcomes of a randomized trial
David Otiashvili, Gvantsa Piralishvili, Zura Sikharulidze, et al.
Journal of Psychiatric Research
|
July 12, 2011
Substance use disorders and comorbid Axis I and II psychiatric disorders among young psychiatric patients: findings from a large electronic health records database
Li-Tzy Wu, Ken Gersing, Bruce Burchett, et al.
The Clinical Journal of Pain
|
December 24, 2010
Economic costs of nonmedical use of prescription opioids
Ryan N Hansen, Gerry Oster, John Edelsberg, et al.
Journal of Substance Abuse Treatment
|
December 3, 2014
Opioid addicted buprenorphine injectors: drug use during and after 12-weeks of buprenorphine-naloxone or methadone in the Republic of Georgia
Gvantsa Piralishvili, David Otiashvili, Zura Sikharulidze, et al.
Drug and Alcohol Dependence
|
December 2, 2009
Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid-dependent youth: secondary analyses from a NIDA Clinical Trials Network study
Amit Chakrabarti, George E Woody, Margaret L Griffin, et al.
The Psychiatric Clinics of North America
|
September 1, 1986
Psychotherapy for substance abuse
G E Woody, A T McLellan, L Luborsky, et al.
Journal of Substance Abuse Treatment
|
January 1, 1990
Detoxification with phenobarbital of alprazolam-dependent polysubstance abusers
N V Ravi, I Maany, W M Burke, et al.
Page
of 15